Background: The number of patients with both cerebrovascular disease and chronic coronary syndrome (CCS) is rising, but shared risk factors are not well understood. This study identifies key risk factors by analyzing clinical data from these patients. Methods: We analyzed 403 patients (203 with intracranial aneurysms, 200 with intracranial stenosis) treated at the Second Affiliated Hospital of Kunming Medical University from June 1, 2022, to July 31, 2024. Data on demographics, medical history, and lab results were collected. Univariate and binary logistic regression analyses were used to identify significant risk factors. Results: Patients with intracranial stenosis and CCS were mostly male and had higher rates of diabetes, hyperhomocysteinemia, elevated NLR, troponin, and BNP. Those with aneurysms and CCS were also predominantly male and showed associations with older age, hypertension, diabetes, alcohol use, aneurysm rupture, and elevated uric acid, lipoprotein(a), homocysteine, and troponin. Logistic regression confirmed that male sex, older age, diabetes, and hyperlipoproteinemia. were independently linked to dual disease. Conclusion: Patients with both cerebrovascular disease and CCS are more likely to be male, older, and have diabetes or hyperlipidemia. These findings support routine cardiovascular risk assessment in this group.
References
[1]
Chen, L.H., Spagnolo-Allende, A., Yang, D., Qiao, Y. and Gutierrez, J. (2024) Epidemiology, Pathophysiology, and Imaging of Atherosclerotic Intracranial Disease. Stroke, 55, 311-323. https://doi.org/10.1161/strokeaha.123.043630
[2]
Li, M., Chen, S., Li, Y., Chen, Y., Cheng, Y., Hu, D., et al. (2013) Prevalence of Unruptured Cerebral Aneurysms in Chinese Adults Aged 35 to 75 Years: A Cross-Sectional Study. AnnalsofInternalMedicine, 159, 514-521. https://doi.org/10.7326/0003-4819-159-8-201310150-00004
[3]
Etminan, N., Chang, H., Hackenberg, K., de Rooij, N.K., Vergouwen, M.D.I., Rinkel, G.J.E., et al. (2019) Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the Population: A Systematic Review and Meta-Analysis. JAMANeurology, 76, 588-597. https://doi.org/10.1001/jamaneurol.2019.0006
[4]
Knuuti, J., Wijns, W., Saraste, A., et al. (2019) ESC Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes. European Heart Journal, 41, 407-477.
[5]
Kolmos, M., Christoffersen, L. and Kruuse, C. (2021) Recurrent Ischemic Stroke—A Systematic Review and Meta-Analysis. JournalofStrokeandCerebrovascularDiseases, 30, Article ID: 105935. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105935
[6]
Nordestgaard, L.T., Christoffersen, M. and Frikke-Schmidt, R. (2022) Shared Risk Factors between Dementia and Atherosclerotic Cardiovascular Disease. InternationalJournalofMolecularSciences, 23, Article No. 9777. https://doi.org/10.3390/ijms23179777
[7]
Ames, B.N., Cathcart, R., Schwiers, E. and Hochstein, P. (1981) Uric Acid Provides an Antioxidant Defense in Humans against Oxidant-and Radical-Caused Aging and Cancer: A Hypothesis. ProceedingsoftheNationalAcademyofSciences, 78, 6858-6862. https://doi.org/10.1073/pnas.78.11.6858
[8]
Borghi, C., Domienik-Karłowicz, J., Tykarski, A., Widecka, K., Filipiak, K.J., Jaguszewski, M.J., et al. (2021) Expert Consensus for the Diagnosis and Treatment of Patient with Hyperuricemia and High Cardiovascular Risk: 2021 Update. CardiologyJournal, 28, 1-14. https://doi.org/10.5603/cj.a2021.0001
[9]
Bahadoran, Z., Mirmiran, P., Kashfi, K. and Ghasemi, A. (2021) Hyperuricemia-induced Endothelial Insulin Resistance: The Nitric Oxide Connection. PflügersArchiv-EuropeanJournalofPhysiology, 474, 83-98. https://doi.org/10.1007/s00424-021-02606-2
[10]
Tanaka, A. and Node, K. (2022) Xanthine Oxidase Inhibition for Cardiovascular Disease Prevention. TheLancet, 400, 1172-1173. https://doi.org/10.1016/s0140-6736(22)01778-0
[11]
Coutinho, T., Turner, S., Peyser, P., Bielak, L., Sheedyii, P. and Kullo, I. (2007) Associations of Serum Uric Acid with Markers of Inflammation, Metabolic Syndrome, and Subclinical Coronary Atherosclerosis. AmericanJournalofHypertension, 20, 83-89. https://doi.org/10.1016/j.amjhyper.2006.06.015
[12]
Huo, Y., Li, J., Qin, X., Huang, Y., Wang, X., Gottesman, R.F., et al. (2015) Efficacy of Folic Acid Therapy in Primary Prevention of Stroke among Adults with Hypertension in China: The CSPPT Randomized Clinical Trial. JAMA, 313, 1325-1335. https://doi.org/10.1001/jama.2015.2274
[13]
Balint, B., Jepchumba, V.K., Guéant, J. and Guéant-Rodriguez, R. (2020) Mechanisms of Homocysteine-Induced Damage to the Endothelial, Medial and Adventitial Layers of the Arterial Wall. Biochimie, 173, 100-106. https://doi.org/10.1016/j.biochi.2020.02.012
[14]
Durga, J., Bots, M.L., Schouten, E.G., Kok, F.J. and Verhoef, P. (2005) Low Concentrations of Folate, Not Hyperhomocysteinemia, Are Associated with Carotid Intima-Media Thickness. Atherosclerosis, 179, 285-292. https://doi.org/10.1016/j.atherosclerosis.2004.10.026
[15]
Zhou, H., Wang, K., Zhou, X., Ruan, S., Gan, S., Cheng, S., et al. (2018) Prevalence and Gender-Specific Influencing Factors of Hypertension among Chinese Adults: A Cross-Sectional Survey Study in Nanchang, China. InternationalJournalofEnvironmentalResearchandPublicHealth, 15, Article No. 382. https://doi.org/10.3390/ijerph15020382
[16]
Xiang, D., Liu, Y., Zhou, S., Zhou, E. and Wang, Y. (2021) Protective Effects of Estrogen on Cardiovascular Disease Mediated by Oxidative Stress. OxidativeMedicineandCellularLongevity, 2021, Article ID: 5523516. https://doi.org/10.1155/2021/5523516
[17]
Liu, S., Li, Y., Zeng, X., Wang, H., Yin, P., Wang, L., et al. (2019) Burden of Cardiovascular Diseases in China, 1990-2016: Findings from the 2016 Global Burden of Disease Study. JAMACardiology, 4, 342-352. https://doi.org/10.1001/jamacardio.2019.0295
[18]
Metz, M., O'Hare, J., Cheng, B., Puchowicz, M., Buettner, C. and Scherer, T. (2023) Brain Insulin Signaling Suppresses Lipolysis in the Absence of Peripheral Insulin Receptors and Requires the MAPK Pathway. MolecularMetabolism, 73, Article ID: 101723. https://doi.org/10.1016/j.molmet.2023.101723
